Vanguard Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15B | Buy |
|
|||||
|
2025
Q1 | $1.15B | Buy |
|
|||||
|
2024
Q4 | $1.68B | Buy |
|
|||||
|
2024
Q3 | $2.69B | Buy |
|
|||||
|
2024
Q2 | $4.7B | Buy |
|
|||||
|
2024
Q1 | $4.16B | Buy |
|
|||||
|
2023
Q4 | $3.37B | Buy |
|
|||||
|
2023
Q3 | $2.86B | Buy |
|
|||||
|
2023
Q2 | $3.34B | Sell |
|
|||||
|
2023
Q1 | $4.23B | Buy |
|
|||||
|
2022
Q4 | $4.9B | Sell |
|
|||||
|
2022
Q3 | $3.25B | Sell |
|
|||||
|
2022
Q2 | $3.95B | Buy |
|
|||||
|
2022
Q1 | $4.66B | Sell |
|
|||||
|
2021
Q4 | $6.97B | Buy |
|
|||||
|
2021
Q3 | $10.5B | Buy |
|
|||||
|
2021
Q2 | $4.75B | Buy |
|
|||||
|
2021
Q1 | $2.48B | Sell |
|
|||||
|
2020
Q4 | $2.44B | Sell |
|
|||||
|
2020
Q3 | $1.97B | Buy |
|
|||||
|
2020
Q2 | $1.65B | Buy |
|
|||||
|
2020
Q1 | $616M | Buy |
|
|||||
|
2019
Q4 | $339M | Buy |
|
|||||
|
2019
Q3 | $271M | Buy |
|
|||||
|
2019
Q2 | $6.21M | Sell |
|
|||||
|
2019
Q1 | $17.7M | Buy |
|
|||||
|
2018
Q4 | $4.96M | Buy |
|